Bridger Management 13F, Q1 2024
Roberto Mignone · quarter ending 31 March 2024 · filed 15 May 2024 · SEC CIK 1166309
Common stock only: shares the fund reported owning at the quarter end, valued as filed.
Largest positions, Q1 2024
The 25 largest of 31 positions. Weights are against the whole filed book. Changes are in shares held, against the Q4 2023 filing.
| Company | Ticker | Value | % of book | vs Q4 2023 |
|---|---|---|---|---|
| UBER TECHNOLOGIES INC | UBER | $23.21M | 10.5% | new |
| ELI LILLY & CO | LLY | $21.84M | 9.8% | new |
| TEVA PHARMACEUTICAL INDS LTD | TEVA | $21.16M | 9.5% | new |
| MORGAN STANLEY | MS | $17.68M | 8.0% | new |
| VERTEX PHARMACEUTICALS INC | VRTX | $17.16M | 7.7% | new |
| BATH & BODY WORKS INC | BBWI | $12.93M | 5.8% | new |
| ENDEAVOR GROUP HLDGS INC | $11.36M | 5.1% | new | |
| PFIZER INC | PFE | $9.73M | 4.4% | new |
| TENET HEALTHCARE CORP | THC | $9.20M | 4.2% | new |
| ALNYLAM PHARMACEUTICALS INC | ALNY | $7.91M | 3.6% | new |
| SPRINGWORKS THERAPEUTICS INC | $7.11M | 3.2% | new | |
| TAIWAN SEMICONDUCTOR MFG LTD | TSM | $7.05M | 3.2% | new |
| CAESARS ENTERTAINMENT INC NE | CZR | $6.46M | 2.9% | new |
| XENON PHARMACEUTICALS INC | XENE | $6.32M | 2.9% | new |
| MELCO RESORTS AND ENTMNT LTD | MLCO | $6.24M | 2.8% | new |
| CYTOKINETICS INC | CYTK | $4.85M | 2.2% | new |
| GERON CORP | GERN | $4.42M | 2.0% | new |
| DEXCOM INC | DXCM | $4.01M | 1.8% | new |
| QUANTERIX CORP | QTRX | $3.65M | 1.6% | new |
| ATRICURE INC | ATRC | $3.04M | 1.4% | new |
| CATALYST PHARMACEUTICALS INC | CPRX | $2.94M | 1.3% | new |
| ALPHABET INC | GOOGL | $2.10M | 0.9% | new |
| UNIQURE NV | $1.88M | 0.8% | new | |
| HILLEVAX INC | $1.80M | 0.8% | new | |
| MICROSOFT CORP | MSFT | $1.78M | 0.8% | new |
What changed since Q4 2023
Against the Q4 2023 filing, Bridger Management opened 29 new positions, added to 0, trimmed 0, left 2 unchanged and exited 0. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.
Other quarters
Source: SEC Form 13F-HR, accession 0001166309-24-000013, filed by BRIDGER MANAGEMENT, LLC. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.
